![]() |
|
|
RESÚMENES DICIEMBRE 2009 |
Other Neuropsychiatric
Disorders & General Information
(Haga un click en la
información del journal
para acceder al resúmen)
5
– doble-ciego o
metanálisis; 4 – subanálisis o simple ciego; 3
– revisión, abierto, básico; 2 –
casos; 1 – opinión
GRATIS = Texto
gratuito en algunos países de la región iberoamericana
2 -
Proarrhythmic risk with antipsychotic and antidepressant drugs: implications in
the elderly
Vieweg
WV, Wood MA, Fernandez A, Beatty-Brooks M, Hasnain M, Pandurangi AK
Drugs
Aging. 2009;26(12):997-1012
3! -
Increased Mortality in Bulimia Nervosa and Other Eating Disorders
Scott J. Crow, Carol B. Peterson,
Sonja A. Swanson, Nancy C. Raymond, Sheila Specker, Elke D. Eckert, and James
E. Mitchell
Am J Psychiatry 2009;
166:1342-1346
1! - The future of drug
development: advancing clinical trial design
John
Orloff, Frank Douglas, Jose Pinheiro, Susan Levinson, Michael Branson, Pravin
Chaturvedi, Ene Ette, Paul Gallo, Gigi Hirsch, Cyrus Mehta, Nitin Patel, Sameer
Sabir, Stacy Springs, Donald Stanski, Matthias R. Evers, Edd Fleming, Navjot
Singh, Tony Tramontin & Howard Golub
Nature Reviews Drug Discovery 8, 949-957 (December
2009)
1! - Lessons from 60 years of pharmaceutical innovation
Bernard Munos
Nature Reviews Drug Discovery 8, 959-968 (December 2009)
3! -
Seizure Threshold in a Large Sample: Implications for Stimulus Dosing
Strategies in Bilateral Electroconvulsive Therapy: A Report From CORE
Petrides,
Georgios; Braga, Raphael J; Fink, Max; Mueller, Martina; Knapp, Rebecca;
Husain, Mustafa; Rummans, Teresa; Bailine, Samuel; Malur, Chitra; O'Connor,
Kevin; Kellner, Charles; for the CORE (Consortium for Research in ECT) Group
The Journal of ECT: December
2009 - Volume 25 - Issue 4 - pp 232-237
3 -
Paroxetine increases brain-derived neurotrophic factor in postmenopausal women
Cubeddu
A, Giannini A, Bucci F, Merlini S, Casarosa E, Pluchino N, Luisi S, Luisi M,
Genazzani AR
Menopause. 2009 Nov 20. [Epub ahead of print]
3 - Fibromyalgia: An
Overview
Daniel J. Clauw
The American Journal of
Medicine. Volume 122, Issue 12, Supplement 1, December 2009, Pages S3-S13
3 - Diagnosis and Differential
Diagnosis of Fibromyalgia
Don L. Goldenberg
The American Journal of
Medicine. Volume 122, Issue 12, Supplement 1, December 2009, Pages S14-S21
3 - Pathophysiology of
Fibromyalgia
Laurence A. Bradley
The American Journal of
Medicine. Volume 122, Issue 12, Supplement 1, December 2009, Pages S22-S30
3 - Further Strategies for
Treating Fibromyalgia: The Role of Serotonin and Norepinephrine Reuptake
Inhibitors
Philip J. Mease
The American Journal of
Medicine. Volume 122, Issue 12, Supplement 1, December 2009, Pages S44-S55
5 -
Selective serotonin reuptake inhibitors provide significant lower
re-hospitalization rates in patients recovering from acute coronary syndromes:
evidence from a meta-analysis
Marianna Mazza, Marzia
Lotrionte, Giuseppe Biondi-Zoccai, Antonio Abbate, Imad Sheiban, and Enrico
Romagnoli
Journal
of Psychopharmacology. First published on December 4, 2009
3 -
Catatonia: Clinical Aspects and Neurobiological Correlates
Jessica Daniels
J Neuropsychiatry Clin
Neurosci 21:371-380, Fall
3 -
Sertraline Improves Executive Function in Patients With Vascular Cognitive
Impairment
Donald R. Royall, Jeffrey A.
Cordes, Gustavo Román, Angela Velez, Aaron Edwards, Jason S. Schillerstrom, and
Marsha J. Polk
J Neuropsychiatry Clin
Neurosci 21:445-454, Fall
GRATIS 3 - Clinical Aspects and
Management of Fibromyalgia Syndrome
Yong-Yeow Chong, Beng-Yeong
Ng
Ann Acad Med Singapore 2009;38:967-73
3 -
Serotonin transporter triallelic genotype and response to citalopram and
risperidone in dementia with behavioral symptoms
Dombrovski,
Alexandre Y; Mulsant, Benoit H; Ferrell, Robert E; Lotrich, Francis E; Rosen,
Jules I; Wallace, Meredith; Houck, Patricia R; Mazumdar, Sati; Pollock, Bruce G
International Clinical Psychopharmacology:
January 2010 - Volume 25 - Issue 1 - pp 37-45
3 -
Combating depression in Huntington's disease: effective antidepressive
treatment with venlafaxine XR
Holl,
Anna K; Wilkinson, Leonora; Painold, Annamaria; Holl, Etienne M; Bonelli,
Raphael M
International Clinical
Psychopharmacology: January 2010 - Volume 25 - Issue 1 - pp 46-50
3 - Rivastigmine
Transdermal Patch Skin Tolerability: Results of a 1-Year Clinical Trial in
Patients with Mild-to-Moderate Alzheimer's Disease
Cummings,
Jeffrey L; Farlow, Martin R; Meng, Xiangyi; Tekin, Sibel; Olin, Jason T
Clinical Drug Investigation: 1
January 2010 - Volume 30 - Issue 1 - pp 41-49
5 - Efficacy
of venlafaxine, medroxyprogesterone acetate, and cyproterone acetate for the
treatment of vasomotor hot flushes in men taking gonadotropin-releasing hormone
analogues for prostate cancer: a double-blind, randomised trial.
Irani
J, Salomon L, Oba R, Bouchard P, Mottet N
Lancet
Oncol. 2009 Dec 4. [Epub ahead of print]
3 - Neuroprotective actions of
selective estrogen receptor modulators
Lydia
L. DonCarlos, Iñigo Azcoitia and Luis M. Garcia-Segura
Psychoneuroendocrinology. Volume
34, Supplement 1, December 2009, Pages S113-S122
3 - Stimulation
of Neurogenesis and Synaptogenesis by Bilobalide and Quercetin via Common Final
Pathway in Hippocampal Neurons
Flaubert Tchantchou, Pascale N. Lacor, Zhiming Cao,
Lixing Lao, Yan Hou, Changhai Cui, William L. Klein, Yuan Luo
Journal
of Alzheimer's Disease. Volume 18, Number 4 / 2009: 787-798
3 - Memantine
Inhibits Calpain-Mediated Truncation of GSK-3 Induced by NMDA: Implications in
Alzheimer's Disease
Paloma
Goñi-Oliver, Jesús Avila, Félix Hernández
Journal
of Alzheimer's Disease. Volume 18, Number 4 / 2009: 843-848
5 - A phase 2 multiple ascending dose trial of
bapineuzumab in mild to moderate Alzheimer disease
S.
Salloway, R. Sperling, S. Gilman, N. C. Fox, K. Blennow, M. Raskind, M.
Sabbagh, L. S. Honig, R. Doody, C. H. van Dyck, R. Mulnard, J. Barakos, K. M.
Gregg, E. Liu, I. Lieberburg, D. Schenk, R. Black, M. Grundman, For the
Bapineuzumab 201 Clinical Trial Investigators
4 - Atomoxetine
Treatment for ADHD. Younger Adults Compared With Older Adults
Todd
Durell, Lenard Adler, Timothy Wilens, Martin Paczkowski, Kory Schuh
Journal
of Attention Disorders, Vol. 13, No. 4, 401-406 (2010)
5 - Effect of Tarenflurbil on Cognitive Decline and Activities of Daily
Living in Patients With Mild Alzheimer Disease. A Randomized Controlled Trial
Robert C. Green, Lon S.
Schneider, David A. Amato, Andrew P. Beelen, Gordon Wilcock, Edward A. Swabb,
Kenton H. Zavitz, for the Tarenflurbil Phase 3 Study Group
3 - Association Between
Attention-Deficit/Hyperactivity Disorder and Sleep Impairment in Adulthood:
Evidence From a Large Controlled Study
Craig B. H. Surman, Joel J.
Adamson, Carter Petty, Joseph Biederman, Deborah C. Kenealy, Madeleine Levine,
Eric Mick, and Stephen V. Faraone
J Clin Psychiatry 2009;70(11):1523–1529
3! - Presenting ADHD Symptoms,
Subtypes, and Comorbid Disorders in Clinically Referred Adults With ADHD
Timothy E. Wilens, Joseph
Biederman, Stephen V. Faraone, MaryKate Martelon, Diana Westerberg, and Thomas
J. Spencer
J Clin Psychiatry 2009;70(11):1557–1562
3 - Direct
Agonist Activity of Tricyclic Antidepressants at Distinct Opioid Receptor
Subtypes
Pierluigi Onali, Simona
Dedoni and Maria C. Olianas
JPET January 2010 vol. 332 no. 1 255-265
3! -
Nelotanserin, a Novel Selective Human 5-Hydroxytryptamine2A Inverse
Agonist for the Treatment of Insomnia
Hussien
A. Al-Shamma, Christen Anderson, Emil Chuang, Remy Luthringer, Andrew J. Grottick, Erin Hauser, Michael Morgan, William Shanahan, Bradley R. Teegarden, William J. Thomsen
and Dominic Behan
JPET January 2010 vol. 332 no. 1 281-290
3 - Excessive
daytime sleepiness in psychiatric disorders: Prevalence, correlates and
clinical significance
Chris J. Hawley, Tim M. Gale,
Thanusha Sivakumaran, Sarita Paul, Venkat Raj Goud Kondan, Ako Farag and Jawad
Shahzad
Psychiatry Research. Volume
175, Issues 1-2, 30 January 2010, Pages 138-141
3! - Principle
standards and problems regarding proof of efficacy in clinical
psychopharmacology
Hans-Jürgen Möller
and Karl Broich
3! - Meta-analyses:
a method to maximise the evidence from clinical studies?
Wolfgang Maier
and Hans-Jürgen Möller
3! - Evidence-based
medicine in psychopharmacotherapy: possibilities, problems and limitations
Hans-Jürgen Möller and
Wolfgang Maier
5 - Effects
of Hormone Therapy on Depressive Symptoms and Cognitive Functions in Women With
Alzheimer Disease: A 12 Month Randomized, Double-Blind, Placebo-Controlled
Study of Low-Dose Estradiol and Norethisterone
Valen-Sendstad,
Arnhild; Engedal, Knut; Stray-Pedersen, Babill; Strobel, Carsten; Barnett, Liv;
Meyer, Nicolay; Nurminemi, Minna; ADACT Study Group
American Journal of Geriatric
Psychiatry: January 2010 - Volume 18 - Issue 1 - pp 11-20
3 - Fluoxetine
response in impulsive-aggressive behavior and serotonin transporter
polymorphism in personality disorder
Silva, Hernán; Iturra, Patricia;
Solari, Aldo; Villarroel, Juana; Jerez, Sonia; Jiménez, Marco; Galleguillos,
Felipe; Bustamante, Maria Leonor
Psychiatric Genetics: February
2010 - Volume 20 - Issue 1 - pp 25-30
3 - The stability of DSM
personality disorders over twelve to eighteen years
Gerald Nestadt, Chongzhi Di, J.F.
Samuels, O.J. Bienvenu, I.M. Reti, P. Costa, William W. Eaton and Karen
Bandeen-Roche
Journal of Psychiatric
Research. Volume 44, Issue 1, January 2010, Pages 1-7
3 - Role
of Antiepileptic Drugs as Preventive Agents for Migraine
Vikelis,
Michail; Rapoport, Alan M
CNS Drugs: 1 January 2010 - Volume 24 - Issue 1 - pp
21-33
3! - Factors
Associated with Serious Adverse Reactions to Cholinesterase Inhibitors: A Study
of Spontaneous Reporting
Pariente,
Antoine; Sanctussy, Dina Joseph-Reinette; Miremont-Salamé, Ghada; Moore,
Nicholas; Haramburu, Françoise; Fourrier-Réglat, Annie; on behalf of
l'Association Française des Centres Régionaux de Pharmacovigilance (CRPV)
CNS Drugs: 1 January 2010 - Volume 24 - Issue 1 - pp
55-63
GRATIS (previo registro) 3 - Síndrome
confusional (delirium) en el anciano
M. Lázaro-Del Nogal, J.M. Ribera-Casado
PSICOGERIATRÍA 2009; 1 (4): 209-221
3 - Lorazepam modulates
orbitofrontal signal changes during emotional processing in catatonia
Andre Richter, Simone Grimm, Georg Northoff
Human Psychopharmacology: Clinical and
Experimental. Volume 25 Issue 1, Pages 55 - 62
5 - Ginkgo biloba for Preventing Cognitive
Decline in Older Adults. A Randomized Trial
Beth E. Snitz, Ellen S.
O’Meara, Michelle C. Carlson, Alice M. Arnold, Diane G. Ives, Stephen R. Rapp, Judith
Saxton, Oscar L. Lopez, Leslie O. Dunn, Kaycee M. Sink, Steven T. DeKosky, for
the Ginkgo Evaluation of Memory (GEM) Study Investigators
3 - Pharmacological
Treatment of Fibromyalgia Syndrome: New Developments
Staud,
Roland
Drugs: 1 January 2010 - Volume 70 - Issue 1 - pp 1-14
3 - Milnacipran:
In Fibromyalgia
Chwieduk,
Claudine M; McCormack, Paul L
Drugs: 1 January 2010 - Volume 70 - Issue 1 - pp
99-108
5 - A Double-Blind, Placebo-Controlled Study of Armodafinil for Excessive
Sleepiness in Patients With Treated Obstructive Sleep Apnea and Comorbid
Depression
Andrew
D. Krystal, John R. Harsh, Ronghua R. Yang, Gregory A. Rippon, and D. Alan
Lankford
J
Clin Psychiatry.Online ahead of print: December 29, 2009
GRATIS 3! - Incidence and Course of Suicidal Ideation and Suicide Attempts in the
General Population
Margreet
ten Have, Ron de Graaf, Saskia van Dorsselaer, Jacqueline Verdurmen, Hedda van’t
Land, Wilma Vollebergh, Aartjan Beekman
Can J Psychiatry. 2009;54(12):824–833
3 - Agents Complexing Copper
as a Therapeutic Strategy for the Treatment of Alzheimer's Disease
Rosanna Squitti, Carlo
Salustri
Current Alzheimer Research.
Volume 6 Issue 6: 476-487
3 - Serotonin-Norepinephrine
Reuptake Inhibitors for Pain Control: Premise and Promise
David M. Marks, Manan J.
Shah, Ashwin A. Patkar, Prakash S. Masand, Geun-Young Park, Chi-Un Pae
Current Neuropharmacology.
Volume 7 Issue 4: 331-336
GRATIS 3! - 2010
Guide to Psychiatric Drug Interactions
Sheldon H. Preskorn, and David Flockhart
Primary Psychiatry.
2009;16(12):45-74
GRATIS 3 - Sleep
in Adults With ADHD and the Effects of Stimulants
Thomas Roth, and Joyce Zinsenheim
Primary Psychiatry.
2009;16(12):32-37
| Regresar a RESÚMENES DICIEMBRE 2009 |
© 1999-2009 Jorge M
Tamayo, MD, BMSS
Creada en Enero 1999
Declaración: El contenido de esta página web está basado en las revisiones de la literatura realizadas por el autor y las colaboraciones enviadas por los lectores. Este sitio de Internet está dirijido únicamente a profesionales de la salud en Iberoamérica. Si usted es residente de Estados Unidos de América o Europa, debe tener en cuenta que los contenidos no han sido escogidos con base en información aprobada por la FDA o la EMEA.